Day: March 14, 2022

Proactive news headlines including Hygrovest, Caspin Resources, Moho Resources and Oklo Resources

Written by Customer Service on March 14, 2022. Posted in Mergers And Acquisitions.

Sydney, March 14, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Hygrovest Ltd (ASX:HGV) is continuing to focus its new investment efforts on themes like disease testing, biotech, cryptocurrencies and decarbonization. Click here Caspin Resources Ltd (ASX:CPN) is a mineral exploration company based in Western Australia and focused on the Yarawindah Brook Project and the Mount Squires Project. Click here Moho Resources Ltd (ASX:MOH) has set the diamond drill rig turning at the Omrah nickel prospect of the Silver Swan North Project in Western Australia, targeting an untested electromagnetic (EM) conductor that was confirmed with geophysical interpretation of historic EM survey data. Click here Oklo Resources Ltd (ASX:OKU)...

Fourth Quarter 2021 Euro and GBP Equivalent Dividend Payments

Written by Customer Service on March 14, 2022. Posted in Dividend Reports And Estimates.

SHELL PLC FOURTH QUARTER 2021 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS March 14, 2022 The Board of Shell plc (“Shell”) today announced the pounds sterling and euro equivalent dividend payments in respect of the fourth quarter 2021 interim dividend, which was announced on February 3, 2022 at US$0.24 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or pounds sterling currency elections by March 4, 2022 will be entitled to a dividend of US$0.24, €0.2181 or 18.28p per ordinary share, respectively. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown above....

Mkango and HyProMag to Collaborate in Major New Grant-Funded Project to Recycle Rare Earth Magnets From Electronic Waste, Electric Motors and Wind Turbines for the UK Supply Chain

Written by Customer Service on March 14, 2022. Posted in Public Companies.

HighlightsMkango Rare Earths UK Ltd (“Mkango UK”) is pleased to announce it will collaborate with HyProMag, Bowers & Wilkins (“B&W Group”), European Metal Recycling (“EMR”), GKN Automotive Innovation Centre (“GKN Automotive”), Jaguar Land Rover and University of Birmingham (“UoB”) in the Driving the Electric Revolution challenge at UK Research and Innovation grant funded project, “Secure Critical Rare Earth Magnets for UK” (“SCREAM” or the “Project”) SCREAM will establish a recycled source of rare earth magnets in the UK to provide greater security of supply to UK industry, whilst aiming to achieve a 10% reduction in cost and a significant reduction in environmental impact, with an estimated 88% less energy for short loop (i.e. magnet to magnet) recycled magnets versus primary mining to separation to metal...

James Brady Joins Verona Pharma as Non-Executive Director

Written by Customer Service on March 14, 2022. Posted in Public Companies.

LONDON and RALEIGH, N.C., March 14, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces Mr. James Brady has joined the board as a Non-Executive Director. Mr. Brady has extensive experience in the biopharmaceutical industry, serving in multiple leadership roles of increasing responsibility across the US, Europe, and China, during his 30-plus-year career at AstraZeneca. He held national, regional, and global finance roles spanning corporate operations, manufacturing, commercial, marketing, market access, audit, international business, and biologics discovery and development. Most recently, Mr. Brady served as Chief Financial Officer of MedImmune, the biologics discovery and development division of AstraZeneca. During his...

Publication of the decree and orders relating to the additional allo-cation of 20 TWh of ARENH volumes for 2022: update of the impact on the 2022 EBITDA outlook

Written by Customer Service on March 14, 2022. Posted in Public Companies.

PRESS RELEASE14 March 2022 Publication of the decree and orders relating to the additional allocation of 20 TWh of ARENH volumes for 2022: update of the impact on the 2022 EBITDA outlook The Government published on 12 March 2022 in the Official Journal the Decree and Orders dated 11 March 2022 relating to the additional allocation of 20 TWh of ARENH volumes for 2022. The Decree provides that eligible suppliers, in order to benefit from the additional ARENH volumes over the period from 1 April to 31 December 2022 at the price of €46.2/MWh, will have to sell EDF the same volume that will be transferred to them by EDF under this additional allocation, at a price equal to the average of the wholesale forward prices recorded between 2 and 23 December 2021, for electricity delivery in mainland France in...

Next Games Annual Report 2021 has been published

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Next Games Corporation Company Release March 14, 2022 at 08:30 EET Next Games’ Annual Report 2020 has been published and is available on the company’s website at https://www.nextgames.com/investors/reports-and-presentations The annual report consists of the Board of Directors’ Report, Financial Statements with notes, Corporate Governance Statement and Remuneration Statement. Next Games’ Annual General Meeting 2022 will be held on Thursday 28 April, 2022. Additional information: Saara BergströmChief Communications Officer+358 (0) 50 483 3896press@nextgames.com Certified Adviser: Alexander Corporate Finance Oy, puh. +358 (0) 50 520 4098 About Next Games Next Games is the first publicly listed mobile game developer and publisher in Finland, specializing in games based on entertainment franchises, such as movies, TV series...

Sampo plc’s share buybacks 11/03/2022

Written by Customer Service on March 14, 2022. Posted in Public Companies.

SAMPO PLC STOCK EXCHANGE RELEASE 14/03/2022 at 08:30 am Sampo plc’s share buybacks 11/03/2022 On 11/03/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code) 9,311 41.49 AQEU 9,870 41.67 CEUX 4,673 41.50 TQEX 88,727 41.60 XHELTOTAL 112,581 41.59 *rounded to two decimals On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021, is...

DNO Shares Traded Ex-Dividend

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Oslo, 14 March 2022 – DNO ASA, the Norwegian oil and gas operator, today announced that the Company’s shares will be traded ex-dividend effective 14 March 2022. A dividend payment of NOK 0.20 per share will be made on or about 21 March to all shareholders of record as of 15 March 2022. – For further information, please contact:Media: media@dno.noInvestors: investor.relations@dno.no – DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom and Yemen. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading...

Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancer

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancerAMEERA-3 trial did not meet primary endpoint of improving progression-free survival Ongoing trials continue as planned, including AMEERA-5 and AMEERA-6Paris, March 14, 2022. The Phase 2 AMEERA-3 clinical trial evaluating amcenestrant, an investigational optimized oral selective estrogen receptor degrader (SERD), did not meet its primary endpoint of improving progression-free survival (PFS) as assessed by an independent central review. The trial evaluated amcenestrant as monotherapy compared to endocrine treatment of physician’s choice in patients with locally advanced or metastatic estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer who progressed on or after hormonal...

MediaCentral Corporation Defends in Civil Claim

Written by Customer Service on March 14, 2022. Posted in Public Companies.

TORONTO, March 13, 2022 (GLOBE NEWSWIRE) — Media Central Corporation (CSE: FLYY, FSE:3AT) or (the “Company”) announced today that it continues to defend itself against a civil claim brought by a former employee dating back to July 2020. The company filed a Form 2 response to Moore, Laura versus Vancouver Free Press Publishing DBA Georgia Straight on September 2, 2020. The company has declined on two occasions to settle the $250,000 claim. The next hearing is scheduled on May 3 and 4, 2022. About Media Central Corporation Inc. Media Central Corporation Inc. is an alternative media company situated to acquire and develop high-quality publishing assets starting with the recent acquisition of Vancouver Free Press Corp., the purchase of NOW Communications Inc. and the launch of digital cannabis platform CannCentral.com and ESports...

Day: March 14, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice